PMGC Holdings Inc. (NASDAQ:ELAB – Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 15th, there was short interest totaling 39,049 shares, a decline of 52.0% from the December 31st total of 81,359 shares. Based on an average daily trading volume, of 1,203,127 shares, the short-interest ratio is presently 0.0 days. Approximately 7.8% of the company’s stock are sold short. Approximately 7.8% of the company’s stock are sold short. Based on an average daily trading volume, of 1,203,127 shares, the short-interest ratio is presently 0.0 days.
PMGC Stock Down 0.6%
ELAB opened at $3.40 on Thursday. PMGC has a 12-month low of $3.03 and a 12-month high of $189.14. The business has a 50 day moving average of $10.45 and a 200-day moving average of $19.88. The stock has a market cap of $1.70 million, a price-to-earnings ratio of -0.05 and a beta of 0.67.
PMGC (NASDAQ:ELAB – Get Free Report) last posted its earnings results on Friday, November 14th. The company reported ($19.80) earnings per share for the quarter. The company had revenue of $0.29 million during the quarter.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on ELAB
PMGC Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.
See Also
- Five stocks we like better than PMGC
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
